Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Sublingual Immunotherapy With House Dust Mite Extract in Asthmatic Children: A Double-Blind, Randomized, and Placebo-Controlled Study

NCT00172341 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT00172341
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00172341 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Sublingual Immunotherapy With House Dust Mite Extract in Asthmatic Children: A Double-Blind, Randomized, and Placebo-Controlled Study
Lead sponsor
National Taiwan University Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
Not reported
Completion date
Not reported
Enrollment
100
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

asthma